StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
39
This year
3
Publishing Date
2024 - 02 - 28
1
2024 - 01 - 30
1
2024 - 01 - 09
1
2023 - 10 - 11
1
2023 - 09 - 12
1
2023 - 08 - 30
1
2023 - 06 - 27
1
2023 - 05 - 01
1
2023 - 04 - 27
1
2023 - 02 - 28
1
2023 - 02 - 01
1
2023 - 01 - 24
1
2023 - 01 - 03
1
2022 - 10 - 11
1
2022 - 06 - 09
2
2022 - 05 - 16
1
2022 - 04 - 19
1
2022 - 03 - 14
1
2022 - 02 - 17
1
2022 - 01 - 04
2
2021 - 12 - 29
1
2021 - 09 - 07
1
2021 - 08 - 16
1
2021 - 07 - 22
1
2021 - 06 - 17
1
2021 - 06 - 16
2
2021 - 05 - 19
1
2021 - 05 - 06
1
2021 - 05 - 04
1
2021 - 04 - 28
1
2021 - 04 - 06
2
2021 - 03 - 10
2
2021 - 02 - 10
1
2021 - 01 - 25
1
Sector
Commercial services
3
Communications
2
Distribution services
2
Health technology
33
Producer manufacturing
1
Technology services
3
Tags
Acquisition
158
Agreement
64
Als
53
Approval
45
Biomidwest
52
Biopharma
250
Biotech-beach
41
Business
80
Cancer
62
Ceo
78
Ces
72
Conference
512
Contract
42
Corporation
250
Deadline
44
Disease
78
Drug
53
Earnings
82
Energy
381
Events
151
Fda
49
Financial
334
Financial results
219
Global
82
Group
68
Growth
216
Iot
46
Layoffs
116
Management
53
Market
142
Medical
45
Meeting
96
Milestone
80
Million
48
Mining
68
N/a
5307
News
64
Offering
142
People
54
Pharm-country
81
Pharmaceuticals
80
Positive
87
Presentation
86
Program
94
Rare
47
Report
240
Research
159
Results
1195
Sales
55
Services
59
Study
60
Technology
68
Test
54
Therapeutics
68
Therapy
60
Treatment
112
Trial
98
Update
205
Uranium
126
Year
153
Entities
Actinium pharmaceuticals, inc.
1
Annovis bio, inc.
7
Applied uv, inc.
1
Can-fite biopharma ltd
6
Cormedix inc.
2
Daxor corporation
3
Document security systems, inc.
3
India globalization capital inc.
2
Issuer direct corporation
3
Kelso technologies inc
1
Lineage cell therapeutics, inc.
1
Matinas biopharma holdings, inc.
1
Milestone scientific, inc.
1
Myomo inc.
2
Navidea biopharmaceuticals, inc.
3
Orange
2
Palatin technologies, inc.
3
Timber pharmaceuticals, inc.
1
Volitionrx limited
1
Xenetic biosciences, inc.
1
Symbols
ANVS
7
ATNM
1
AUVI
1
CANF
6
CRMD
2
DSS
3
DXR
3
FNCTF
2
IGC
2
ISDR
3
KIQ
1
LCTX
1
MLSS
1
MTNB
1
MYO
2
NAVB
3
PTN
3
TMBR
1
VNRX
1
XBIO
1
Exchanges
Amex
39
Nasdaq
1280
Nyse
179
Crawled Date
2024 - 02 - 28
1
2024 - 01 - 30
1
2024 - 01 - 09
1
2023 - 10 - 11
1
2023 - 09 - 12
1
2023 - 08 - 30
1
2023 - 06 - 27
1
2023 - 05 - 01
1
2023 - 04 - 27
1
2023 - 02 - 28
1
2023 - 02 - 01
1
2023 - 01 - 24
1
2023 - 01 - 03
1
2022 - 10 - 11
1
2022 - 06 - 09
2
2022 - 05 - 16
1
2022 - 04 - 19
1
2022 - 03 - 14
1
2022 - 02 - 17
1
2022 - 01 - 04
2
2021 - 12 - 29
1
2021 - 09 - 07
1
2021 - 08 - 16
1
2021 - 07 - 22
1
2021 - 06 - 17
1
2021 - 06 - 16
2
2021 - 05 - 19
1
2021 - 05 - 06
1
2021 - 05 - 04
1
2021 - 04 - 28
1
2021 - 04 - 06
2
2021 - 03 - 24
1
2021 - 03 - 10
2
2021 - 02 - 10
1
Crawled Time
07:00
1
11:00
1
12:00
4
12:15
2
12:20
1
12:30
3
13:00
9
13:11
1
13:15
2
13:30
2
13:46
1
14:00
2
15:00
2
16:00
2
17:00
1
18:02
1
21:00
1
22:00
2
23:00
1
Source
irdirect.net
1
www.biospace.com
20
www.daxor.com
1
www.globenewswire.com
9
www.igcinc.us
2
www.myomo.com
2
www.palatin.com
1
www.prnewswire.com
3
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Patent
exchanges :
Amex
save search
Can-Fite Broadens its Strong Intellectual Property (IP) for NASH: Received Patent Allowance in Canada
Published:
2024-02-28
(Crawled : 12:30)
- biospace.com/
CANF
|
$1.99
1.02%
-0.5%
7.8K
|
Health Technology
|
-5.71%
|
O:
-1.9%
H:
4.37%
C:
0.98%
patent
canada
Annovis Bio Announces the Filing of New Patent Application for Treatment of Mental Illnesses Expanding the Company’s Portfolio
Published:
2024-01-30
(Crawled : 13:00)
- globenewswire.com
ANVS
|
$10.09
2.44%
-0.15%
220K
|
Health Technology
|
-11.6%
|
O:
5.45%
H:
0.0%
C:
-10.42%
patent
treatment
application
DAXOR AWARDED ADDITIONAL NEW PATENT FOR SMART BLOOD VOLUME GUIDANCE TECHNOLOGY TO IMPROVE TREATMENT AND OUTCOMES
Published:
2024-01-09
(Crawled : 13:00)
- globenewswire.com
DXR
|
$9.74
0.73%
8.3K
|
Health Technology
|
-1.59%
|
O:
-0.98%
H:
0.75%
C:
-0.1%
patent
treatment
blood
smart
technology
Lineage Announces Issuance of U.S. Patent Covering Proprietary Manufacturing and Differentiation Process for Retinal Pigmented Epithelial Cells
Published:
2023-10-11
(Crawled : 13:00)
- biospace.com/
LCTX
|
$1.15
-4.17%
0.0%
1.1M
|
Health Technology
|
-14.18%
|
O:
-1.49%
H:
0.76%
C:
-3.03%
patent
Kelso Technologies Inc. Key Patent Application Filed for Automated Traction Optimization Method for Vehicle Suspension Systems
Published:
2023-09-12
(Crawled : 13:30)
- globenewswire.com
KIQ
|
$0.1349
0.0%
12K
|
Producer Manufacturing
|
-42.33%
|
O:
0.47%
H:
0.0%
C:
-6.38%
patent
application
CorMedix Inc. Announces Issuance of U.S. Patent Covering Lead Product Defencath
Published:
2023-08-30
(Crawled : 12:00)
- globenewswire.com
CRMD
|
News
|
$5.27
-2.77%
-2.85%
2M
|
Health Technology
|
28.47%
|
O:
0.24%
H:
0.49%
C:
-0.97%
patent
Annovis Bio Announces the Filing of a Groundbreaking Patent
Published:
2023-06-27
(Crawled : 13:00)
- biospace.com/
ANVS
|
$10.09
2.44%
-0.15%
220K
|
Health Technology
|
-28.45%
|
O:
3.13%
H:
0.34%
C:
-1.66%
patent
CorMedix Inc. Announces Notice of Allowance for U.S. Patent Application Covering Lead Product DefenCath
Published:
2023-05-01
(Crawled : 13:00)
- biospace.com/
FNCTF
|
News
|
$11.0354
-20.84%
320
|
Communications
|
-14.54%
|
O:
0.36%
H:
0.0%
C:
0.0%
CRMD
|
News
|
$5.27
-2.77%
-2.85%
2M
|
Health Technology
|
6.88%
|
O:
0.4%
H:
3.43%
C:
3.23%
patent
application
Annovis Bio Announces Issuance of U.S. Patent Covering the Use of Lead Drug Candidate, Buntanetap, for Prevention or Treatment of Disease States Due to Metal Dis-Homeostasis in Healthy or Sick Humans
Published:
2023-04-27
(Crawled : 11:00)
- globenewswire.com
ANVS
|
$10.09
2.44%
-0.15%
220K
|
Health Technology
|
-32.3%
|
O:
2.36%
H:
1.52%
C:
-1.18%
drug
patent
disease
treatment
Palatin Issued Patent on Vyleesi® (Bremelanotide Injection) For Hypoactive Sexual Desire Disorder in Patients With Controlled Hypertension
Published:
2023-02-28
(Crawled : 13:00)
- palatin.com
PTN
|
$1.84
-2.65%
0.05%
150K
|
Health Technology
|
-31.21%
|
O:
9.16%
H:
9.59%
C:
8.56%
vyleesi
patent
hypertension
Annovis Bio Announces Filing of Patent Covering the Administration of Buntanetap and Its Analogues for the Treatment of Mental Illnesses
Published:
2023-02-01
(Crawled : 13:00)
- prnewswire.com
ANVS
|
$10.09
2.44%
-0.15%
220K
|
Health Technology
|
-39.1%
|
O:
4.3%
H:
7.43%
C:
4.76%
treatment
patent
buntanetap
Can-Fite: Namodenoson Significantly Inhibits Pancreatic Cancer in Preclinical Studies—A Patent Has Been Filed
Published:
2023-01-24
(Crawled : 13:00)
- biospace.com/
CANF
|
$1.99
1.02%
-0.5%
7.8K
|
Health Technology
|
-60.87%
|
O:
1.98%
H:
3.87%
C:
-8.14%
namodenoson
patent
preclinical
cancer
pancreatic
Navidea Biopharmaceuticals Announces the Notice of Allowance for U.S. Patent Application for Key Component of the Company’s Cancer Immunotherapy Pipeline
Published:
2023-01-03
(Crawled : 14:00)
- biospace.com/
NAVB
|
$0.035
50.69%
15K
|
Health Technology
|
-80.95%
|
O:
10.0%
H:
29.09%
C:
16.88%
patent
immunotherapy
application
cancer
Xenetic Biosciences, Inc. Announces Signing of Patent Assignment Related to Collaboration With VolitionRx Limited and CLS Therapeutics
Published:
2022-10-11
(Crawled : 13:00)
- biospace.com/
XBIO
|
$4.14
7.32%
770
|
Health Technology
|
-92.63%
|
O:
5.26%
H:
0.0%
C:
-4.15%
VNRX
|
$0.616
-0.19%
0.0%
250K
|
Health Technology
|
-61.25%
|
O:
-0.63%
H:
0.0%
C:
-5.03%
patent
collaboration
therapeutics
Annovis Bio Submits an International Patent Application to Cover the Treatment of Neurological Injuries Caused by Infections
Published:
2022-06-09
(Crawled : 14:00)
- biospace.com/
ANVS
|
$10.09
2.44%
-0.15%
220K
|
Health Technology
|
-26.57%
|
O:
0.8%
H:
0.0%
C:
-14.19%
treatment
patent
neurological
application
infections
international
IGC Receives U.S. Patent for Method and Composition for Treating Seizure Disorders
Published:
2022-06-09
(Crawled : 07:00)
- igcinc.us
IGC
4
|
$0.49
2.92%
0.74%
610K
|
Health Technology
|
15.4%
|
O:
48.37%
H:
14.13%
C:
-1.3%
patent
Can-Fite Granted Key NASH Patent in Israel
Published:
2022-05-16
(Crawled : 12:20)
- biospace.com/
CANF
|
$1.99
1.02%
-0.5%
7.8K
|
Health Technology
|
130.53%
|
O:
4.79%
H:
0.0%
C:
-4.44%
patent
israel
granted
nash
grant
Navidea Biopharmaceuticals Announces the Notice of Allowance for U.S. Patent Application for Diagnosis and Treatment of Leishmaniasis
Published:
2022-04-19
(Crawled : 12:00)
- biospace.com/
NAVB
|
$0.035
50.69%
15K
|
Health Technology
|
-95.35%
|
O:
20.93%
H:
0.0%
C:
0.0%
treatment
patent
application
diagnostic
Can-Fite: Namodenoson’s Treatment of Liver Fibrosis Receives Notice of Allowance from U.S. Patent Office
Published:
2022-03-14
(Crawled : 12:30)
- biospace.com/
CANF
|
$1.99
1.02%
-0.5%
7.8K
|
Health Technology
|
104.12%
|
O:
6.19%
H:
4.85%
C:
-8.49%
treatment
fibrosis
patent
liver
namodenoson
Myomo Strengthens Intellectual Property Portfolio with Receipt of Key Patent in Japan
Published:
2022-02-17
(Crawled : 22:00)
- myomo.com
MYO
4
|
$3.19
13.12%
-2.19%
320K
|
Distribution Services
|
-57.75%
|
O:
0.66%
H:
1.55%
C:
-2.37%
patent
intel
← Previous
1
2
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.